Le Lézard
Classified in: Health
Subjects: AWD, NPT, STP, AVO

New Jersey Senate to honor Partnership for a Drug-Free New Jersey Chair Elaine Pozycki


TRENTON, N.J., June 21, 2018 /PRNewswire-USNewswire/ -- The New Jersey Senate will be honoring Elaine Pozycki for her leadership in addressing New Jersey's opioid epidemic by presenting a resolution at 2 p.m. today at the Statehouse.

Partnership for a Drug-Free New Jersey Co-Chair Elaine Pozycki will be honored with a resolution by the New Jersey Senate for her leadership in combating New Jersey's opioid crisis.

Elaine, co-chair of the Partnership for a Drug-Free New Jersey, spearheaded the legislative efforts in New Jersey that resulted in the patient notification law, passed in February 2017, that now requires all New Jersey practitioners, prior to prescribing an opioid, to have a conversation with their patients on the addictive nature of the medications, as well possible non-opioid alternatives that are available.

The law also requires physicians, physician assistants, dentists and optometrists to complete one Continuing Medical Education credit on topics that include responsible prescribing practices, as well as risks and signs of opioid abuse, addiction and diversion.

"I am humbled and honored to receive this recognition and especially want to thank Senator Vitale and all the members of the New Jersey Senate for their support in the passage of the patient notification legislation that is saving lives every day in our state and nation," Pozycki said.

Realizing the need for the law to be enacted throughout the United States, Elaine and her husband, Steven, launched a national campaign called Prevent Opioid Abuse.

Versions of this groundbreaking legislation have now been adopted in five additional states (Rhode Island, Connecticut, Maryland, Nevada and Michigan) and are being considered by dozens of other state legislatures for adoption.

Best known for its statewide substance use prevention advertising campaign, the Partnership for a Drug-Free New Jersey is a private not-for-profit coalition of professionals from the communications, corporate and government communities whose collective mission is to reduce demand for illicit drugs in New Jersey through media communication. To date, more than $100 million in broadcast time and print space has been donated to the Partnership's New Jersey campaign, making it the largest public service advertising campaign in New Jersey's history. Since its inception the Partnership has garnered 166 advertising and public relations awards from national, regional and statewide media organizations.

SOURCE Partnership for a Drug-Free New Jersey


These press releases may also interest you

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...



News published on and distributed by: